INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 424m ago
HOUSE PTR24m ago
SEC 13F23m ago
ROBINHOOD CHAIN23m ago
Corporate insider
WT

Watanabe Todd

Director, See RemarksCIK 0001801061

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 4
Max Insider Score30
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
WT
Watanabe ToddDirector, See Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL$139K
4,377 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Arcutis Biotherapeutics, Inc.Director, See Remarks · Nov 5, 2025
14
WT
Watanabe ToddDirector, See Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL
$75K
3,172 sh
May 4, 2026
May 6, 2026
traded May 4, 2026
+2d
SEC FORM 4

Evidence

26
WT
Watanabe ToddDirector, See Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$284K
11.5K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

20
WT
Watanabe ToddDirector, See Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1,753
69 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence